Incyte Earnings, Revenue Beat in Q2
2022.08.02 15:50
Incyte Earnings, Revenue Beat in Q2
Investing.com – Incyte (NASDAQ:INCY) reported on Tuesday second quarter earnings that beat analysts’ forecasts and revenue that topped expectations.
Incyte announced earnings per share of $1.01 on revenue of $911.4M. Analysts polled by Investing.com anticipated EPS of $0.5573 on revenue of $814.9M.
Incyte shares are down 20.31% from the beginning of the year, still down 8.79% from its 52 week high of $84.86 set on April 8. They are under-performing the S&P 500 which is down 13.59% from the start of the year.
Incyte follows other major Healthcare sector earnings this month
Incyte’s report follows an earnings beat by UnitedHealth on July 15, who reported EPS of $5.57 on revenue of $80.33B, compared to forecasts EPS of $5.21 on revenue of $79.68B.
J&J had beat expectations on July 19 with second quarter EPS of $2.59 on revenue of $24.02B, compared to forecast for EPS of $2.54 on revenue of $23.77B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
